Fingerprint
Dive into the research topics of 'Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically